Title
MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability
Date Issued
01 August 2017
Access level
open access
Resource Type
journal article
Author(s)
Ylikallio E.
Woldegebriel R.
Tumiati M.
Isohanni P.
Ryan M.M.
Stark Z.
Walsh M.
Sawyer S.L.
Bell K.M.
Oshlack A.
Lockhart P.J.
Shcherbii M.
Atkinson D.
Hartley T.
Tetreault M.
Cuppen I.
Van Der Pol W.L.
Candayan A.
Battaloglu E.
Parman Y.
Van Gassen K.L.I.
Van Den Boogaard M.J.H.
Boycott K.M.
Kauppi L.
Jordanova A.
Lönnqvist T.
Tyynismaa H.
Murdoch Childrens Research Institute
Publisher(s)
Oxford University Press
Abstract
Defects in mRNA export from the nucleus have been linked to various neurodegenerative disorders. We report mutations in the gene MCM3AP, encoding the germinal center associated nuclear protein (GANP), in nine affected individuals from five unrelated families. The variants were associated with severe childhood onset primarily axonal (four families) or demyelinating (one family) Charcot-Marie-Tooth neuropathy. Mild to moderate intellectual disability was present in seven of nine affected individuals. The affected individuals were either compound heterozygous or homozygous for different MCM3AP variants, which were predicted to cause depletion of GANP or affect conserved amino acids with likely importance for its function. Accordingly, fibroblasts of affected individuals from one family demonstrated severe depletion of GANP. GANP has been described to function as an mRNA export factor, and to suppress TDP-43-mediated motor neuron degeneration in flies. Thus our results suggest defective mRNA export from nucleus as a potential pathogenic mechanism of axonal degeneration in these patients. The identification of MCM3AP variants in affected individuals from multiple centres establishes it as a disease gene for childhood-onset recessively inherited Charcot-Marie-Tooth neuropathy with intellectual disability.
Start page
2093
End page
2103
Volume
140
Issue
8
Language
English
OCDE Knowledge area
Neurociencias Neurología clínica
Scopus EID
2-s2.0-85028361063
PubMed ID
Source
Brain
ISSN of the container
00068950
Sponsor(s)
Patient A’s sequencing was completed as part of a study funded and supported by the Melbourne Genomic Health Alliance. This work was supported in part by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Whole exome sequencing for Family C was performed as part of the Care4Rare Canada Consortium, funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, and Children’s Hospital of Eastern Ontario Foundation. Analysis of the Turkish family is supported partially by Bogazici University Research Fund Grant Number 14B01D5. The following funding sources are also gratefully acknowledged: Academy of Finland (H.T., E.Y., L.K.), Sigrid Juselius Foundation (H.T., L.K.), University of Helsinki (H.T., E.Y., M.T.), Biocentrum Helsinki (L.K.), Finska läkaresällskapet (E.Y.), Helsinki University Hospital (E.Y.), Foundation for Pediatric Research (P.I.), Fund for Scientific Research-Flanders (FWO) (A.J.), University of Antwerp (A.J.), Belgium Association for Neuromuscular Disorders (ABMM) (A.J.), research fellowships from the Fund for Scientific Research-Flanders (FWO) (D.A.,A.E.-C), NHMRC Career Development Fellowship (GNT1032364) (P.J.L).
Sources of information: Directorio de Producción Científica Scopus